Glenmark launches Milieus in Kolkata

Kolkata, Jan 4: Glenmark Pharmaceuticals Limited, one of the leading Indian pharmaceutical companies, has launched "Milieus" in Bengal to cater to the needs of general practitioners (GP) in metros, non-metros and rural areas across the country.

The products marketed by Milieus, a division of Glenmark, are backed by world-class technology and research at affordable prices, a release said.

Milieus' range of product target is therapy segments like anti-infective, cough and cold, analgesics and anti-inflammatory and gastroenterology. These products are low priced so as to make them affordable to the masses in urban as well as rural areas.

Milieus aims to bridge the price gap that has arisen post January 1,2005 due to the slow development and limited access of the masses to public health infrastructure, it said.

The Indian pharmaceutical market is worth Rs 26778 crore (ORG-IMS MAT October 2006). There are around five lakh doctors in the country and GPs constitute 60 per cent of this population. GPs are the first point of contact for patients and also attend to the entire family due to which they enjoy a personal rapport.

West Bengal is the fourth largest pharmaceutical market in India, growing at a rate of 31 per cent. It contributes to 9.3 per cent of the total Indian pharmaceutical market at Rs 2,487 crore and to 11.2 per cent of Glenmark's sales in India.

In addition to Milieus, Glenmark has eight other specialised divisions, namely, Glenmark, majesta, Gracewell, Intergrace, Healtheon, Zollan, Onkos etc.

UNI